AMA submission to the Inquiry into the Regulator of Medicinal Cannabis Bill 2014

The AMA believes the current system adequately provides for the regulation of therapeutic narcotics.  Medicinal cannabis should be held to the same standards of evidence, safety, quality, and efficacy as other therapeutic narcotic products.   This will ensure that medicinal cannabis can be standardised and regulated in its pharmaceutical preparations and administration, thereby reducing the harm to potential users.  

The full AMA submission to the Senate Legal and Constitutional Affairs Legislation Committee inquiry into the Regulator of Medicinal Cannabis Bill 2014 is attached below.